[Ottawa Chapter] Accelerating Innovation: How AI is Redefining BioTech

The S2BN Ottawa chapter is hosting a panel session with two expert guests, Joseph Geraci (NetraMark) and Naheed Kurji (Recursion Canada). Grab asome caffeine and come ready with questions. The panel discussion will be split into the follow 3 topics:

• AI in drug discovery: data collection, trials, and effect on future diagnostics & treatment. • AI ethical ambiguity: job placements, false positives/negatives. • Entrepreneurship in starting and managing an AI company.

Please find more about the invited panelists below:

Joseph Geraci, Ph.D. (NetraMark)

Dr. Joseph Geraci, Ph.D., is a mathematician, medical scientist, and quantum machine learning specialist. He is the founder of NetraMark. Geraci holds postdocs in machine learning, oncology, and neuropsychiatry. He has developed novel machine learning intelligence algorithms that are capable of providing extraordinary insights into complex data sets, like those found in clinical trials. Joseph is associated with the Department of Molecular Medicine and Pathology at…